Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityMortgagesNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acme United (ACU) Cash & Equivalents: 2010-2025

Historic Cash & Equivalents for Acme United (ACU) over the last 15 years, with Sep 2025 value amounting to $5.1 million.

  • Acme United's Cash & Equivalents fell 9.75% to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 million, marking a year-over-year decrease of 9.75%. This contributed to the annual value of $6.4 million for FY2024, which is 33.42% up from last year.
  • Per Acme United's latest filing, its Cash & Equivalents stood at $5.1 million for Q3 2025, which was up 41.33% from $3.6 million recorded in Q2 2025.
  • Acme United's Cash & Equivalents' 5-year high stood at $6.4 million during Q4 2024, with a 5-year trough of $1.8 million in Q2 2022.
  • For the 3-year period, Acme United's Cash & Equivalents averaged around $4.3 million, with its median value being $3.8 million (2024).
  • Examining YoY changes over the last 5 years, Acme United's Cash & Equivalents showed a top increase of 93.24% in 2023 and a maximum decrease of 47.92% in 2023.
  • Acme United's Cash & Equivalents (Quarterly) stood at $4.8 million in 2021, then grew by 25.95% to $6.1 million in 2022, then dropped by 21.38% to $4.8 million in 2023, then surged by 33.42% to $6.4 million in 2024, then decreased by 9.75% to $5.1 million in 2025.
  • Its Cash & Equivalents was $5.1 million in Q3 2025, compared to $3.6 million in Q2 2025 and $3.4 million in Q1 2025.